Cargando…

Protein kinase CK2: a potential therapeutic target for diverse human diseases

CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates hundreds of substrates, controls several signaling pathways, and is implicated in a plethora of human diseases. Its best documented role is in cancer, where it regulates practically all malignant hallmarks. Other well-known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borgo, Christian, D’Amore, Claudio, Sarno, Stefania, Salvi, Mauro, Ruzzene, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126563/ https://www.ncbi.nlm.nih.gov/pubmed/33994545 http://dx.doi.org/10.1038/s41392-021-00567-7

Ejemplares similares

Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance
por: D’Amore, Claudio, et al.
Publicado: (2020)

Role of protein kinase CK2 in antitumor drug resistance
por: Borgo, Christian, et al.
Publicado: (2019)

Targeting CK2 in cancer: a valuable strategy or a waste of time?
por: Salvi, Mauro, et al.
Publicado: (2021)

Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons
por: Lettieri, Antonella, et al.
Publicado: (2019)

KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR
por: D’Amore, Claudio, et al.
Publicado: (2022)

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells
por: Di Maira, Giovanni, et al.
Publicado: (2019)

Analysis of the phosphoproteome of CK2α((–/–))/Δα′ C2C12 myoblasts compared to the wild-type cells
por: Borgo, Christian, et al.
Publicado: (2023)

Development of small cyclic peptides targeting the CK2α/β interface
por: Atkinson, Eleanor L., et al.
Publicado: (2022)

Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells
por: Zonta, Francesca, et al.
Publicado: (2021)

Editorial of Special Issue “Protein Post-Translational Modifications in Signal Transduction and Diseases”
por: D’Amore, Claudio, et al.
Publicado: (2021)

Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells
por: Alcaraz, Estefania, et al.
Publicado: (2020)

Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate
por: Fabbian, Simone, et al.
Publicado: (2022)

Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells
por: Kreutzer, Jan N, et al.
Publicado: (2010)

Exploring the CK2 Paradox: Restless, Dangerous, Dispensable
por: Franchin, Cinzia, et al.
Publicado: (2017)

Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants
por: Borgo, Christian, et al.
Publicado: (2022)

Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management
por: Lian, Haiwei, et al.
Publicado: (2019)

Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice
por: Ferrer-Font, Laura, et al.
Publicado: (2017)

Therapeutic targeting of CK2 in acute and chronic leukemias
por: Buontempo, F, et al.
Publicado: (2018)

Different Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDB
por: Girardi, Cristina, et al.
Publicado: (2015)

Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells
por: Zanin, Sofia, et al.
Publicado: (2012)

Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington’s Disease
por: White, Angel, et al.
Publicado: (2022)

Phosphorylation of p23-1 cochaperone by protein kinase CK2 affects root development in Arabidopsis
por: D’Alessandro, Stefano, et al.
Publicado: (2019)

Generation and quantitative proteomics analysis of CK2α/α’((−/−)) cells
por: Borgo, Christian, et al.
Publicado: (2017)

Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise
por: Trembley, Janeen H., et al.
Publicado: (2022)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies
por: Salizzato, Valentina, et al.
Publicado: (2016)

Activity of CK2α protein kinase is required for efficient replication of some HPV types
por: Piirsoo, Alla, et al.
Publicado: (2019)

Targeting protein kinase CK2 in the treatment of cholangiocarcinoma
por: Jayaraman, Padma-Sheela, et al.
Publicado: (2021)

Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain
por: Ottaviani, Daniele, et al.
Publicado: (2017)

The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131
por: Vilardell, Jordi, et al.
Publicado: (2018)

Malaria Protein Kinase CK2 (PfCK2) Shows Novel Mechanisms of Regulation
por: Graciotti, Michele, et al.
Publicado: (2014)

The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation
por: Cozza, Giorgio, et al.
Publicado: (2015)

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection
por: Ramón, Ailyn C., et al.
Publicado: (2022)

CK2 is a key regulator of SLC4A2-mediated Cl(−)/HCO(3)(−) exchange in human airway epithelia
por: Ibrahim, Salam H., et al.
Publicado: (2017)

Protein Kinase CK2 in Cancer Energetics
por: Silva-Pavez, Eduardo, et al.
Publicado: (2020)

CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
por: Chua, Melissa M.J., et al.
Publicado: (2017)

Modulation of Protein Kinase CK2 Activity by Fragments of CFTR Encompassing F508 May Reflect Functional Links with Cystic Fibrosis Pathogenesis
por: Pagano, Mario A., et al.
Publicado: (2008)

Protein Kinase CK2—A Putative Target for the Therapy of Diabetes Mellitus?
por: Ampofo, Emmanuel, et al.
Publicado: (2019)

Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia
por: Bruserud, Øystein, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3rf8plr0fscka047u4ohumauno